Gelsemium sempervirens and animal behavioral models

Frontiers in Pharmacology

Volumn SEP, Issue , 2011, Pages

  Bellavite Paolo, P ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; GELSEMINE; GELSEMIUM SEMPERVIRENS EXTRACT; GLYCINE RECEPTOR; NEUROSTEROID; PLACEBO; PLANT EXTRACT; PLANT TOXIN; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANXIETY; BEHAVIOR DISORDER; CONCENTRATION (PARAMETERS); DILUTION; DISEASE MODEL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EXPERIMENTAL TEST; FEAR; GELSEMIUM; GELSEMIUM SEMPERVIRENS; INTERNAL BIAS; LIGHT DARK TEST; LOW DRUG DOSE; NONHUMAN; NOTE; OPEN FIELD TEST; PHYTOTOXICITY; PLACEBO EFFECT; PSYCHOPHARMACOLOGY; STEROIDOGENESIS; STUDY DESIGN; TOXICITY TESTING; TRANQUILIZING ACTIVITY; URINALYSIS;

EID: 84866004091     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fneur.2011.00056     Document Type: Note

References (12)

1. Bellavite, P., Magnani, P., Marzotto, M., and Conforti, A. (2009). Assays of homeopathic remedies in rodent behavioural and psychopathological models. Homeopathy 98, 208-227.
2. Belzung, C., and Griebel, G. (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125, 141-149.
3. Bourin, M., and Hascoet, M. (2003). The mouse light/ dark box test. Eur. J. Pharmacol. 463, 55-65.
4. Bourin, M., Petit-Demouliere, B., Dhonnchadha, B. N., and Hascoet, M. (2007). Animal models of anxiety in mice. Fundam. Clin. Pharmacol. 21, 567-574.
5. Chen, S. W., Min, L., Li, W. J., Kong, W. X., Li, J. F., and Zhang, Y. J. (2004). The effects of angelica essential oil in three murine tests of anxiety. Pharmacol. Biochem. Behav. 79, 377-382.
6. Chirumbolo, S. (2011). Gelsemine and Gelsemium sempervirens L. extracts in animal behavioral test: comments and related biases. Front. Neurol. 2:31. doi: 10.3389/fneur.2011.00031
7. Dutt, V., Dhar, V. J., and Sharma, A. (2010). Antianxiety activity of Gelsemium sempervirens. Pharm. Biol. 48, 1091-1096.
8. Lai, C. K., and Chan, Y. W. (2009). Confirmation of Gelsemium poisoning by targeted analysis of toxic Gelsemium alkaloids in urine. J. Anal. Toxicol. 33, 56-61.
9. Magnani, P., Conforti, A., Zanolin, E., Marzotto, M., and Bellavite, P. (2010). Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl.) 210, 533-545.
10. Prut, L., and Belzung, C. (2003). The open field as a para- digm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 463, 3-33.
11. Venard, C., Boujedaini, N., Belon, P., Mensah-Nyagan, A. G., and Patte-Mensah, C. (2008). Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 153, 154-161.
12. Venard, C., Boujedaini, N., Mensah-Nyagan, A. G., and Patte-Mensah, C. (2009). Comparative analysis of gelsemine and Gelsemium sempervirens activity on neurosteroid allopregnanolone formation in the spi- nal cord and limbic system. Evid. Based Complem. Alternat. Med. 2009, 1-9. doi: 10.1093/ecam/nep083